S Royce1, S Khann2, R P Yadav2, E T Mao3, A Cattamanchi4, S Sam5, M A Handley1. 1. Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA. 2. Cambodia Office, World Health Organization, Phnom Penh, Cambodia. 3. National Centre for Tuberculosis and Leprosy Control, Phnom Penh, Cambodia. 4. Department of Medicine, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA. 5. Cambodian Health Committee, Phnom Penh, Cambodia.
Abstract
SETTING: Previously treated tuberculosis (TB) patients are a priority for drug susceptibility testing (DST) to identify cases with multidrug-resistant TB (MDR-TB). A Cambodia study found that one third of smear-positive previously treated patients had DST results. OBJECTIVE: To quantify the gaps in the detection of MDR-TB in previously treated TB patients in Cambodia, and describe health workers' perspectives on barriers, facilitators and potential interventions. DESIGN: Analysis of Cambodia's 2004-2012 case notifications and semi-structured interviews with stakeholders. RESULTS: The proportion of previously treated notifications varied significantly across provinces in 2010-2012. If there had been no attrition along the path to detecting MDR-TB among smear-positive notified cases in 2012, an estimated 75 additional MDR-TB cases could have been identified, which would double the number actually detected. Most were lost due to misclassification of previously treated patients as 'new'. Barriers include patients' reluctance to disclose and staff difficulty in eliciting treatment history, partly attributed to the availability of streptomycin (SM) only in hospitals. Facilitators include collection of sputum for DST even if previously treated patients are not receiving SM, streamlining sputum transportation and prompt reporting of results. CONCLUSION: Improved monitoring, supportive staff supervision and training, patient education, and correct classification of previously treated cases are essential for improving the detection of MDR-TB.
SETTING: Previously treated tuberculosis (TB) patients are a priority for drug susceptibility testing (DST) to identify cases with multidrug-resistant TB (MDR-TB). A Cambodia study found that one third of smear-positive previously treated patients had DST results. OBJECTIVE: To quantify the gaps in the detection of MDR-TB in previously treated TB patients in Cambodia, and describe health workers' perspectives on barriers, facilitators and potential interventions. DESIGN: Analysis of Cambodia's 2004-2012 case notifications and semi-structured interviews with stakeholders. RESULTS: The proportion of previously treated notifications varied significantly across provinces in 2010-2012. If there had been no attrition along the path to detecting MDR-TB among smear-positive notified cases in 2012, an estimated 75 additional MDR-TB cases could have been identified, which would double the number actually detected. Most were lost due to misclassification of previously treated patients as 'new'. Barriers include patients' reluctance to disclose and staff difficulty in eliciting treatment history, partly attributed to the availability of streptomycin (SM) only in hospitals. Facilitators include collection of sputum for DST even if previously treated patients are not receiving SM, streamlining sputum transportation and prompt reporting of results. CONCLUSION: Improved monitoring, supportive staff supervision and training, patient education, and correct classification of previously treated cases are essential for improving the detection of MDR-TB.
Authors: A M Kilale; B J Ngowi; G S Mfinanga; S Egwaga; B Doulla; A M V Kumar; M Khogali; J van Griensven; A D Harries; R Zachariah; S G Hinderaker Journal: Public Health Action Date: 2013-06-21
Authors: M Yagui; M T Perales; L Asencios; L Vergara; C Suarez; G Yale; C Salazar; M Saavedra; S Shin; O Ferrousier; P Cegielski Journal: Int J Tuberc Lung Dis Date: 2006-08 Impact factor: 2.373
Authors: Margaret A Handley; Marisela Robles; Eric Sanford; Natalie Collins; Hilary Seligman; Triveni Defries; Ramona Perez; Jim Grieshop Journal: Glob Public Health Date: 2012-10-22
Authors: Sarabjit S Chadha; B N Sharath; Kishore Reddy; Jyothi Jaju; P H Vishnu; Sreenivas Rao; Malik Parmar; Srinath Satyanarayana; Kuldeep Singh Sachdeva; Nevin Wilson; Anthony D Harries Journal: PLoS One Date: 2011-11-02 Impact factor: 3.240
Authors: Dick Menzies; Andrea Benedetti; Anita Paydar; Sarah Royce; Pai Madhukar; William Burman; Andrew Vernon; Christian Lienhardt Journal: PLoS Med Date: 2009-09 Impact factor: 11.069